Advertisement
EKTAY vs SAUHY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKTAY is a Hold and SAUHY is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EKTAY’s FA Score shows that 2 FA rating(s) are green whileSAUHY’s FA Score has 0 green FA rating(s).
- EKTAY’s FA Score: 2 green, 3 red.
- SAUHY’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EKTAY’s TA Score shows that 4 TA indicator(s) are bullish while SAUHY’s TA Score has 5 bullish TA indicator(s).
- EKTAY’s TA Score: 4 bullish, 6 bearish.
- SAUHY’s TA Score: 5 bullish, 4 bearish.
Price Growth
EKTAY (@Medical/Nursing Services) experienced а +0.15% price change this week, while SAUHY (@Pharmaceuticals: Other) price change was +8.84% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.41%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +6.50%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +0.12%, and the average quarterly price growth was +6.19%.
Reported Earning Dates
SAUHY is expected to report earnings on Feb 18, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.41% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+1.62% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| EKTAY | SAUHY | EKTAY / SAUHY | |
| Capitalization | 1.83B | 20.4B | 9% |
| EBITDA | 2.23B | 721M | 310% |
| Gain YTD | -12.553 | 5.869 | -214% |
| P/E Ratio | 63.25 | 37.88 | 167% |
| Revenue | 17.8B | 2.58B | 690% |
| Total Cash | 2.76B | 335M | 824% |
| Total Debt | 7.74B | N/A | - |
EKTAY | SAUHY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 86 | 5 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 37 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 83 | |
SMR RATING 1..100 | 87 | 54 | |
PRICE GROWTH RATING 1..100 | 75 | 46 | |
P/E GROWTH RATING 1..100 | 5 | 86 | |
SEASONALITY SCORE 1..100 | 37 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EKTAY's Valuation (6) in the null industry is in the same range as SAUHY (37). This means that EKTAY’s stock grew similarly to SAUHY’s over the last 12 months.
SAUHY's Profit vs Risk Rating (83) in the null industry is in the same range as EKTAY (100). This means that SAUHY’s stock grew similarly to EKTAY’s over the last 12 months.
SAUHY's SMR Rating (54) in the null industry is somewhat better than the same rating for EKTAY (87). This means that SAUHY’s stock grew somewhat faster than EKTAY’s over the last 12 months.
SAUHY's Price Growth Rating (46) in the null industry is in the same range as EKTAY (75). This means that SAUHY’s stock grew similarly to EKTAY’s over the last 12 months.
EKTAY's P/E Growth Rating (5) in the null industry is significantly better than the same rating for SAUHY (86). This means that EKTAY’s stock grew significantly faster than SAUHY’s over the last 12 months.
| EKTAY | SAUHY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 53% | 2 days ago 64% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 49% | N/A |
| TrendWeek ODDS (%) | 2 days ago 62% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 73% |
| Advances ODDS (%) | 2 days ago 64% | 2 days ago 69% |
| Declines ODDS (%) | 4 days ago 61% | 9 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 65% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 69% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FIDAX | 19.20 | 0.18 | +0.95% |
| JHancock Financial Industries A | |||
| BBTIX | 13.76 | 0.09 | +0.66% |
| Bridge Builder Tax Managed Intl Eq | |||
| HDPBX | 28.93 | 0.16 | +0.56% |
| Hodges Blue Chip Equity Income Retail | |||
| OMCIX | 52.05 | 0.01 | +0.02% |
| Oberweis Micro Cap Institutional | |||
| VRTIX | 376.57 | -1.13 | -0.30% |
| Vanguard Russell 2000 Index I | |||
EKTAY and
Correlation & Price change
A.I.dvisor tells us that EKTAY and SAUHY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKTAY and SAUHY's prices will move in lockstep.
| Ticker / NAME | Correlation To EKTAY | 1D Price Change % | ||
|---|---|---|---|---|
| EKTAY | 100% | +1.66% | ||
| SAUHY - EKTAY | 31% Poorly correlated | +0.93% | ||
| SMMNY - EKTAY | 29% Poorly correlated | +1.44% | ||
| PHG - EKTAY | 29% Poorly correlated | +0.17% | ||
| GNGBY - EKTAY | 26% Poorly correlated | N/A | ||
| NEOG - EKTAY | 26% Poorly correlated | -0.92% | ||
More | ||||
SAUHY and
Correlation & Price change
A.I.dvisor indicates that over the last year, SAUHY has been loosely correlated with SONVY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SAUHY jumps, then SONVY could also see price increases.
| Ticker / NAME | Correlation To SAUHY | 1D Price Change % | ||
|---|---|---|---|---|
| SAUHY | 100% | +0.93% | ||
| SONVY - SAUHY | 49% Loosely correlated | +1.75% | ||
| ALGN - SAUHY | 49% Loosely correlated | -1.94% | ||
| SAUHF - SAUHY | 47% Loosely correlated | +7.34% | ||
| SMMNY - SAUHY | 44% Loosely correlated | +1.44% | ||
| CZMWY - SAUHY | 38% Loosely correlated | +2.43% | ||
More | ||||